In vitro susceptibility of Staphylococcus aureus and Staphylococcus epidermidis isolated from prosthetic joint infections

Journal of Antibiotics

Volumn 65, Issue 10, 2012, Pages 505-508

  Molina Manso, Diana ^a   Del Prado, Gema ^a   Ortiz Pérez, Alberto ^a   Manrubia Cobo, Miguel ^a   Gómez Barrena, Enrique ^b   Cordero Ampuero, José ^c   Esteban, Jaime ^a  

^a UAM)   (Spain)

^b HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^c HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

Author keywords

infection; joint; prostheses; Staphylococcus; susceptibility

Indexed keywords

CLINDAMYCIN; CLOXACILLIN; COTRIMOXAZOLE; DAPTOMYCIN; FOSFOMYCIN; RIFAMPICIN; TIGECYCLINE; VANCOMYCIN;

ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; BACTERIUM ISOLATE; BACTERIUM ISOLATION; BIOFILM; BROTH DILUTION; CORRELATION ANALYSIS; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PERIPROSTHETIC JOINT INFECTION; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS;

ANTI-BACTERIAL AGENTS; HUMANS; MICROBIAL SENSITIVITY TESTS; MICROBIAL VIABILITY; OSTEOARTHRITIS; PROSTHESIS-RELATED INFECTIONS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS;

STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS;

EID: 84868137953     PISSN: 00218820     EISSN: 18811469     Source Type: Journal    
DOI: 10.1038/ja.2012.62     Document Type: Article

References (33)

1. Lentino, J. R. Prosthetic joint infections: bane of orthopedists, challenge for infectious disease specialists. Clin. Infect. Dis. 36, 1157-1161 (2003
2. Anagnostakos, K., Schmid, N. V., Kelm, J., Grun, U. & Jung, J. Classification of hip joint infections. Int. J. Med. Sci. 6, 227-233 (2009
3. Trampuz, A. & Zimmerli, W. Prosthetic joint infections: Update in diagnosis and treatment. Swiss Med. Wkly. 135, 243-251 (2005
4. Bernard, L. et al. Trends in the treatment of orthopaedic prosthetic infections. J. Antimicrob. Chemother. 53, 127-129 (2004
5. Geipel, U. Pathogenic organisms in hip joint infections. Int. J. Med. Sci. 6, 234-240 (2009
6. Del Pozo, J. L. & Patel, R. Clinical practice. Infection associated with prosthetic joints. N. Engl. J. Med. 361, 787-794 (2009
7. Parvizi, J., Azzam, K., Ghanem, E., Austin, M. S. & Rothman, R. H. Periprosthetic infection due to resistant staphylococci: Serious problems on the horizon. Clin. Orthop. Relat. Res. 467, 1732-1739 (2009
8. Cremniter, J. et al. Decreased susceptibility to teicoplanin and vancomycin in coagulase-negative Staphylococci isolated from orthopedic-device-Associated infections. J. Clin. Microbiol. 48, 1428-1431 (2010
9. Hawser, S. P., Bouchillon, S. K., Hoban, D. J., Dowzicky, M. & Babinchak, T. Rising incidence of Staphylococcus aureus with reduced susceptibility to vancomycin and susceptibility to antibiotics: A global analysis 2004-2009. Int. J. Antimicrob. Agents 37, 219-224 (2011
10. Rice, D. A. & Mendez-Vigo, L. Daptomycin in bone and joint infections: A review of the literature. Arch. Orthop. Trauma Surg. 129, 1495-1504 (2009
11. Drancourt, M. et al. Oral rifampin plus ofloxacin for treatment of Staphylococcusinfected orthopedic implants. Antimicrob. Agents Chemother. 37, 1214-1218 (1993
12. Stein, A. et al. Ambulatory treatment of multidrug-resistant Staphylococcus-infected orthopedic implants with high-dose oral co-trimoxazole (trimethoprim-sulfamethoxazole). Antimicrob. Agents Chemother. 42, 3086-3091 (1998
13. Saginur, R. et al. Multiple combination bactericidal testing of staphylococcal biofilms from implant-Associated infections. Antimicrob. Agents Chemother. 50, 55-61
14. Gallo, J. et al. In vitro testing of gentamicin-vancomycin loaded bone cement to prevent prosthetic joint infection. Biomed. Pap. Med. Fac. Univ. Palacky Olomouc. Czech Repub 149, 153-158 (2005
15. Bassetti, M. et al. Linezolid in the treatment of Gram-positive prosthetic joint infections. J. Antimicrob. Chemother. 55, 387-390 (2005
16. Esteban, J. & Cordero-Ampuero, J. Treatment of prosthetic osteoarticular infections. Expert Opin. Pharmacother. 12, 899-912 (2011
17. Valle, J. et al. SarA and not sigmaB is essential for biofilm development by Staphylococcus aureus. Mol. Microbiol. 48, 1075-1087 (2003
18. Esteban, J. et al. Evaluation of quantitative analysis of cultures from sonicated retrieved orthopedic implants in diagnosis of orthopedic infection. J. Clin Microbiol. 46, 488-492 (2008
19. CLSI. Performance Standards for Antimicrobial Susceptibility Testing. Twenty-first informational supplement. In M100-S21 Vol 31 No 1 (2012
20. EUCAST. Breakpoint tables for interpretation of MICs and zone diameters. In Version 2.0 (2012
21. Amsterdam, D. Susceptibility testing of antimicrobials in liquid media. In Antibiotics in Laboratory Medicine (Ed., V.L.) 102-103 (Williams & Wilkins, Philadelphia,(1996
22. Schito, G. C. The importance of the development of antibiotic resistance in Staphylococcus aureus. Clin. Microbiol. Infect. 12 (Suppl 1) 3-8 (2006
23. Deurenberg, R. H. et al. The molecular evolution of methicillin-resistant Staphylococcus aureus. Clin. Microbiol. Infect. 13, 222-235 (2007
24. von Eiff, C. Staphylococcus aureus small colony variants: A challenge to microbiologists and clinicians. Int. J. Antimicrob. Agents 31, 507-510 (2008
25. Schafer, P. et al. Prolonged bacterial culture to identify late periprosthetic joint infection: A promising strategy. Clin. Infect. Dis. 47, 1403-1409 (2008
26. Vaudaux, P., Kelley, W. L. & Lew, D. P. Staphylococcus aureus small colony variants: Difficult to diagnose and difficult to treat. Clin. Infect. Dis. 43, 968-970 (2006
27. Sendi, P. et al. Staphylococcus aureus small colony variants in prosthetic joint infection. Clin. Infect. Dis. 43, 961-967 (2006
28. Kourbatova, E. V. et al. Emergence of community-Associated methicillin-resistant Staphylococcus aureus USA 300 clone as a cause of health care-Associated infections among patients with prosthetic joint infections. Am. J. Infect. Control\ 33, 385-391 (2005
29. Vindel, A. et al. Methicillin-resistant Staphylococcus aureus in Spain: Molecular epidemiology and utility of different typing methods. J. Clin. Microbiol. 47, 1620-1627 (2009
30. Srinivasan, A., Dick, J. D. & Perl, T. M. Vancomycin resistance in staphylococci. Clin. Microbiol. Rev. 15, 430-438 (2002
31. Zimmerli, W., Widmer, A. F., Blatter, M., Frei, R. & Ochsner, P. E. Role of rifampin for treatment of orthopedic implant-related staphylococcal infections: A randomized controlled trial. Foreign-Body Infection (FBI) Study Group. JAMA 279, 1537-1541 (1998
32. Picazo, J. J. et al. Comparative activities of daptomycin and several agents against staphylococcal blood isolates. Glycopeptide tolerance. Diagn. Microbiol. Infect. Dis. 70, 373-379 (2011
33. Sader, H. S., Fritsche, T. R. & Jones, R. N. Daptomycin bactericidal activity and correlation between disk and broth microdilution method results in testing of Staphylococcus aureus strains with decreased susceptibility to vancomycin. Antimicrob. Agents Chemother. 50, 2330-2336 (2006